These results are consistent with prior studies by our own group demonstrating IGF1R to be a therapeutic target in primary medulloblastoma tumorspheres from a transgenic mouse model of medulloblastoma35 as well as reports of IGF1R expression in human medulloblastoma36. This evidence concerns the gene IGF1R and medulloblastoma.